Immune Checkpoint Blockade in Hepatocellular Carcinoma

Publisher： Karger

E-ISSN： 1664-5553|4|4|201-207

ISSN： 2235-1795

Source： Liver Cancer, Vol.4, Iss.4, 2015-0, pp. : 201-207

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Immune Checkpoint Blockade in Hepatocellular Carcinoma: 2017 Update

By  

Liver Cancer, Vol. 6, Iss. 1, 2016-11 ,pp. : 1-12

Karger

Access to resources Recommend Favorite

Recent Trends in the Management of Hepatocellular Carcinoma with Special Emphasis on Treatment with Regorafenib and Immune Checkpoint Inhibitors

By  

Digestive Diseases, Vol. 34, Iss. 6, 2016-10 ,pp. : 714-730

Karger

Access to resources Recommend Favorite

Immune Responses in Hepatocellular Carcinoma

By  

Digestive Diseases, Vol. 28, Iss. 1, 2010-05 ,pp. : 150-154

Karger

Access to resources Recommend Favorite

Cellular Immune Suppressor Mechanisms in Patients with Hepatocellular Carcinoma

By  

Digestive Diseases, Vol. 30, Iss. 5, 2012-10 ,pp. : 477-482

Karger

Access to resources Recommend Favorite

Cellular Immune Responses to Hepatocellular Carcinoma: Lessons for Immunotherapy

By  

Digestive Diseases, Vol. 30, Iss. 5, 2012-10 ,pp. : 483-491

Karger

Access to resources Recommend Favorite